BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FABP1
,
calcium channel activity
,
Leukemia
,
Endothelial cell
,
Avian flu virus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
dalteparin
Summary
General Info
Curated Studies
Most Correlated Studies
Breast cancer MCF-7 cell line treated with unfractionated heparin or low molecular weigh heparins
Polysomal RNA from 483 T-ALL cells treated with cap-dependent translation inhibitor
T-cell acute lymphoblastic leukemic cells treated with 4EGI1 - polysomal & cytoplasmic RNA fractions
Explore Curated Studies Results
Literature
Most Relevant Literature
Haemorrhagic complications in patients with renal insufficiency during treatment or prophylaxis with…
A phase 2 pharmacodynamic dose-finding, safety, and efficacy study of dalteparin for pediatric venou…
Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites…
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial.
Renal function and clinical outcome of patients with cancer-associated venous thromboembolism random…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Thrombophylaxis in Transurethral Surgery With Dalteparine
Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated …
Dalteparin in Preventing DVT in Participants With Cancer
A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients
Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That i…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ